I've recently seen a lot of contradicting articles about Novo Nordisk's future.
For example:
* Their new pill didn’t hit the 25% weight loss mark, but it still achieved over 22%, which is pretty solid.
* Ozempic’s patent is set to expire in March 2026, but it’s unclear if any competitors are close to getting an approved alternative.
I’m struggling to make sense of it all. Does anyone with experience in this space have insight into whether Novo Nordisk is in a strong long-term position, or if it might be better to sell?